Dundee biomedical scientist wins award for writing on PV testing

A Dundee-based biomedical scientist has won the 2020 Bernie Benson Prize for his science writing. The competition sought to promote the understanding and exploration of blood viscosity testing.

Contact tracing app security flaws

The CEO of a British technology company has warned the government of potential serious flaws in the security of personal information and data used in the new contact tracing app technology that was announced by Matt Hancock.

New RNase Inhibitor ensures reliable RNA protection

PCR Biosystems has launched RiboShield RNase Inhibitor, a robust and reliable RNase inhibitor that is now available as a standalone product.

Global COVID-19 long-term study launched

Researchers and clinicians in Glasgow will lead a global study into the long-term health impacts of COVID-19, and are inviting hospitals and healthcare sites worldwide to join this new initiative.

SARS-CoV-2 ELISA laboratory test launched

Avacta Group, the developer of Affimer biotherapeutics and reagents, has announced its intention to launch an ELISA laboratory test for the SARS-CoV-2 spike protein to support global research efforts into the coronavirus that causes COVID-19.

Viral transport media production scaled up in response to SARS-CoV-2

Teknova, a manufacturer of cell culture media and supplements, protein purification buffers, and molecular biology reagents, has responded to the SARS-CoV-2 pandemic by significantly scaling up production of Viral Transport Medium (VTM) and saline.

Rapid SARS-CoV-2 antigen test manufacturing capacity expanded

Avacta Group, the developer of Affimer biotherapeutics and reagents, has entered an agreement with Abingdon Health for the manufacture of its saliva-based rapid SARS-CoV-2 antigen test as part of an ongoing expansion of manufacturing capacity.

Expanded SARS-CoV-2 testing with electrochemiluminescence immunoassay

Avero Diagnostics, a physician-owned US laboratory, has announced the expansion of its COVID-19 testing portfolio with the addition of the Roche Elecsys anti-SARS-CoV-2 antibody test.

Deployment of novel, cost-effective SARS-CoV-2 vaccine technology

Edinburgh-based biotechnology company Ingenza has made a significant breakthrough in the race to develop and manufacture a cost-effective vaccine against SARS-CoV-2, the virus responsible for the current pandemic and COVID-19 disease.

Reducing viral replication by aryl hydrocarbon receptor inhibition

Hercules Pharmaceuticals has announced the publication of promising preclinical in vivo trial results showing efficacy of its aryl hydrocarbon receptor (AhR) inhibitor HP163 against Zika virus infection and potentially against coronavirus.

Executive War College: ongoing virtual interactive sessions

Remarkable things are happening as laboratories and anatomical pathology groups answer the challenges of the SARS-CoV-2 pandemic and the need for greater numbers of virus tests. Despite shortages, laboratories are adding SARS-CoV-2 test capacity.

Molecular transport medium optimised for molecular testing

PrimeStore MTM is a molecular transport medium that provides a ‘snapshot’ in time of a sample by preserving and stabilising DNA and RNA. This means that samples can be collected, transported, and processed safely and efficiently.

Antibodies for SARS-CoV-2 virus detection

ViroStat has released a set of new monoclonal antibodies to the nucleocapsid of the SARS-CoV-2 virus. These five antibodies were selected from a group of 60 based on highest binding affinity and best ELISA pairing to detect native viral antigen.

Winter multiplex virus detection kit

Pro-Lab Diagnostics has announced that final-stage clinical trials are underway on the VIASURE Winter Multiplex CFR kit, which is expected to achieve CE certification by the end of August. Preliminary data show excellent performance characteristics.

Clinical validation of Adeptrix COVID-19 diagnostic test

Avacta Group, the developer of Affimer biotherapeutics and reagents, has begun work with the UK government’s CONDOR programme to evaluate and validate the high-throughput COVID-19 bead-assisted mass spectrometry (BAMS) assay developed with Adeptrix.

Molecular transport medium for dual SARS-CoV-2 and influenza sampling

EKF Diagnostics has added a novel viral transport media for the safe sample handling and testing of multiple infectious diseases from a single swab to its product range. PrimeStore MTM is a collection device that deactivates viruses.

Production of Platelia SARS-CoV-2 Total Ab test accelerated

Bio-Rad Laboratories is accelerating production of its Platelia SARS-CoV-2 Total Ab test, a blood-based immunoassay kit to help determine if an individual has developed antibodies to SARS-CoV-2, the virus associated with COVID-19 disease.

Prepare for a winter COVID-19 peak, warns Academy of Medical Sciences

The UK must prepare now for a potential new wave of coronavirus infections this winter that could be more serious than the first, says a new report from the Academy of Medical Sciences.

Novel sensors to detect SARS-CoV-2 coronavirus in waste water

Avacta Group, the developer of Affimer biotherapeutics and reagents, is collaborating with Integumen to evaluate recently generated Affimer reagents that bind the SARS-CoV-2 spike protein for the detection of the coronavirus in waste water.

Increasing efficiency of coronavirus sampling kit production

Xebios Diagnostics manufactures high-quality, ready-to-use culture media for microbiological diagnostic applications, and is using DOSE IT to aliquot viral transport medium (VTM) into sterile screw-capped tubes to meet market demand.